| Kimberly Debruin, OTR/L | |
|
2500 Pond Vw, Suite 102a, Castleton, NY 12033-9750 | |
| (518) 477-6072 | |
| (518) 477-6074 |
| Full Name | Kimberly Debruin |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 2500 Pond Vw, Castleton, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346494341 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 012930-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Debruin, OTR/L 3166 Lone Pine Rd, Schenectady, NY 12303-5037 Ph: (518) 396-2521 | Kimberly Debruin, OTR/L 2500 Pond Vw, Suite 102a, Castleton, NY 12033-9750 Ph: (518) 477-6072 |
News Archive
An increase in the number of injection drug users (IDUs) in eastern and southern Africa stands to harm efforts to control the spread of HIV/AIDS in the region, warned experts gathered at the World Forum Against Drug conference in Sweden on Monday, Agence France-Presse reports.
The federal government has allocated only about 2 percent of its transportation funds to encourage walking and cycling, not nearly enough to make a significant difference, according to Ralph Buehler, associate professor and chair of the urban affairs and planning program in the Virginia Tech School of Public and International Affairs.
Current knowledge about the role of aerosols in the transmission of SARS-CoV-2 warrants urgent attention.
Aeterna Zentaris Inc. today announced that the Michael E. DeBakey Veterans Affairs Medical Center, in Houston, Texas, has initiated a Phase 2A trial assessing the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130 (macimorelin), in patients with cancer cachexia.
A new study has demonstrated that a protein called Niemann-Pick C1 (NPC1) is critical for the Ebola virus to infect a host. The study, published in the May/June issue of mBio, the online open-access journal of the American Society for Microbiology, suggests that drugs that block NPC1 could be used to treat this deadly disease.
› Verified 5 days ago
Amber Synakowski, OTA Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 Pond Vw, Suite 102a, Castleton, NY 12033 Phone: 518-477-6072 Fax: 518-477-6074 | |
Kristin Menegio, COTA/L Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 Pond Vw, Suite 102a, Castleton, NY 12033 Phone: 518-477-6072 Fax: 518-477-6074 |